michellejurika13g010108.htm

SEC
1745 (02-02)
 
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
 

 
OMB APPROVAL
 
OMB Number 3235-0145
 
Expires: December 31, 2008
 
Estimated average burden hours per response . . . 11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.)*


QuadraMed Corporation
(Name of Issuer)
 
COMMON STOCK
(Title of Class of Securities)
 
74730W101
(CUSIP Number)
 
January 1, 2008
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[   ]  Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


 
 
 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.  74730W101
1.     Names of Reporting Persons.  MICHELLE JURIKA
 
        I.R.S. Identification Nos. of above persons (entities only).
 
2.     Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)   X
 
3.     SEC Use Only
 
4.     Citizenship or Place of Organization—UNITED STATES
 
Number of Shares Beneficially Owned by Each Reporting Person With
5.         Sole Voting Power---3,334,222. These shares consist of 18,700 shares of Common Stock held by the Michelle Jurika, IRA (the “IRA”), 3,165,522 shares of Common Stock held by the Jurika Family Trust, U/A 1989 (the “Trust”), and 150,000 shares of Common Stock held by Counterpoint Fund, L.P. (the “L.P.”), the Trust owning 39.7% of the L.P., which is managed by Jurika, Mills, & Kiefer, LLC (“JMK”), with William K. Jurika acting as the managing member of JMK.
 
6.         Shared Voting Power---0.
 
7.         Sole Dispositive Power—3,334,222.  These shares consist of 268,000 shares of Common Stock held by the IRA, 3,165,522 shares of Common Stock held by the Trust, and 150,000 shares of Common Stock held by the L.P., the Trust owning 39.7% of the L.P., which is managed by JMK, with William K. Jurika acting as the managing member of JMK.
 
8.         Shared Dispositive Power---0.
 
9.      Aggregate Amount Beneficially Owned by Each Reporting Person---3,334,222
 
10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
11.   Percent of Class Represented by Amount in Row (9) 7.5%
 
12.   Type of Reporting Person (See Instructions) IN
 


 
2
 

Item 1.
 
 
 
(a)
Name of Issuer
 
QUADRAMED CORPORATION
 
 
 
(b)
Address of Issuer’s Principal Executive Offices
 
12110 SUNSET HILLS ROAD
RESTON, VIRGINIA 20190

Item 2.
 
 
(a)
Name of Person Filing
 
MICHELLE JURIKA
 
 
(b)
Address of Principal Business Office or, if none, Residence
 
42 GLEN ALPINE ROAD
PIEDMONT, CA 94611
 
 
(c)
Citizenship
 
UNITED STATES (place of organization)
 
 
(d)
Title of Class of Securities
 
COMMON STOCK
 
 
(e)
CUSIP Number 74730W101
 
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
[   ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
(b)
[   ]
Bank is defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
(c)
[   ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
(d)
[   ]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
 
(e)
[   ]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
 
(f)
[   ]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
 
(g)
[   ]
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
 
(h)
[   ]
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i)
[   ]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
(j)
[   ]
Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

 

 
3
 

Item 4.                        Ownership
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
 
 
(a)
Amount beneficially owned: 3,334,222.
 
(b)        Percent of class: 7.5%.
 
(c)        Number of shares as to which the person has:
 
 
(i)
Sole power to vote or to direct the vote 3,334,222.
 
 
(ii)
Shared power to vote or to direct the vote 0.
 
 
(iii)
Sole power to dispose or to direct the disposition of 3,334,222.
 
 
(iv)
Shared power to dispose or to direct the disposition of 0.
 
Instruction.  For computations regarding securities which represent a right to acquire an underlying security see § 240.13d3(d)(1).
 
Item 5.
Ownership of Five Percent or Less of a Class
 
N/A
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
N/A

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 
N/A
 
Item 8.
Identification and Classification of Members of the Group.
 
N/A
 
Item 9.
Notice of Dissolution of Group
 
N/A
 

 
4
 

Item 10.
Certification
 
 
 
(b)
The following certification shall be included if the statement is filed pursuant to § 240.13d-1(c):
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: February 18, 2007
  
   
 
/s/ Derek E. Anderson                                                                  
 
Attorney-in-fact, Michelle Jurika
 
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations
      (See 18.U.S.C.)

 

 
 
 
 
 
 
5